ASTERA LABS INC SEC Filings

Astera Labs CEO Jitendra Mohan executed planned sales of common stock on June 20, 2025, through a pre-established Rule 10b5-1 trading plan from December 2024. The transactions involved the sale of approximately 52,743 shares at weighted average prices ranging from $100.00 to $101.73 per share.

The sales were distributed across multiple trusts:

• Living Trust: 8,790 shares (remaining: 4,342,220 shares)
• Trust: 8,793 shares (remaining: 762,210 shares)
• 2021 Trust 1 & 2: 8,790 shares each (remaining: 762,217 shares each)
• 2022 Trust 1 & 2: 8,790 shares each (remaining: 512,218 shares each)

Mohan maintains direct ownership of 2,262,318 shares and serves as both Director and CEO. The filing includes standard disclaimers regarding beneficial ownership of trust-held securities.

Director Manuel Alba of Astera Labs (ALAB) reported multiple stock sales executed on June 20, 2025, through a pre-established Rule 10b5-1 trading plan from May 2024. The transactions involved:

• Casa Alameda 2007 LLC sold 3,709 shares at weighted average prices between $100.63-101.25 per share
• Alba Trust disposed of 16,441 shares at similar price ranges of $100.63-101.25 per share

Following these transactions, Alba maintains beneficial ownership of: 432,854 shares through Casa Alameda LLC, 1,967,757 shares via Alba Trust, 5,000 shares through spouse, and 2,351 shares directly. The filing includes disclaimers regarding beneficial ownership of trust and LLC holdings, limiting claims to Alba's pecuniary interests. All sales were executed according to the automated trading plan, demonstrating planned portfolio management rather than reactive selling.

A Form 144 filing for Astera Labs indicates a proposed sale of 686 shares of common stock with an aggregate market value of $60,368. The sale is planned to be executed through UBS Financial Services on the NASDAQ exchange, with an approximate sale date of June 24, 2025.

The shares were acquired on June 23, 2025, through a Restricted Stock Unit (RSU) grant from the issuer. The current total shares outstanding for the company is 164,916,814.

Key details:

• Share price implied by filing: ~$88 per share
• Transaction represents approximately 0.0004% of total shares outstanding
• No other securities were sold by the filer during the past 3 months
• Sale will be executed on NASDAQ through UBS Financial Services

Astera Labs President and COO Sanjay Gajendra executed multiple stock sales on June 18, 2025, through a pre-planned Rule 10b5-1 trading arrangement established on November 30, 2024. The transactions included:

• 52,933 shares sold at weighted average price of $98.3779
• 4,926 shares sold at weighted average price of $99.2065
• Two separate sales of 9,257 shares each at approximately $98.19 per share

Following these transactions, Gajendra's beneficial ownership stands at:

• 2,262,318 shares held directly
• 5,930,545 shares in Trust 1
• 715,000 shares each in Trust 2 and Trust 3

The sales were executed automatically under the trading plan, demonstrating structured portfolio management by the insider. Gajendra maintains significant ownership through both direct holdings and trust arrangements, while disclaiming beneficial ownership of trust-held shares except for his pecuniary interest.

Jitendra Mohan, Chief Executive Officer and Director of Astera Labs (ALAB), reported multiple sales of common stock on June 17, 2025, executed through a pre-established Rule 10b5-1 trading plan from December 2, 2024.

The transactions involved the sale of 106,510 total shares at a weighted average price of $94.5417 per share across six different trusts. The sales were executed in multiple tranches with prices ranging from $93.36 to $96.78 per share.

Following the transactions, Mohan's holdings are distributed as follows:

• Direct ownership: 2,262,318 shares
• Indirect ownership through various trusts: - Living Trust: 4,351,010 shares - Trust: 771,003 shares - 2021 Trusts: 1,542,014 shares combined - 2022 Trusts: 1,042,016 shares combined

The filing indicates Mohan disclaims beneficial ownership of the trust-held securities except for his pecuniary interest.

Astera Labs, Inc. (ALAB) filed a Form S-8 on 18 June 2025 to register 9,721,048 additional shares of common stock for issuance under two employee equity programs:

• 2024 Stock Option & Incentive Plan: 8,100,874 shares
• 2024 Employee Stock Purchase Plan: 1,620,174 shares

The filing relies on General Instruction E, incorporating the prior S-8 (File No. 333-278078, 20 Mar 2024). Astera is classified as a non-accelerated filer and an emerging growth company. Key exhibits include the legal opinion (5.1), auditor consent (23.1) and plan documents (99.1, 99.2). By registering these shares, the company preserves capacity to issue equity to employees as outlined in its 10-K (14 Feb 2025), 10-Q (7 May 2025) and recent 8-Ks (3 Mar & 10 Jun 2025), all of which are incorporated by reference.